ARWR (Arrowhead Pharmaceuticals, Inc.) Institutional Ownership Summary
Based on the latest SEC 13F filings, 6 institutional investors hold ARWR (Arrowhead Pharmaceuticals, Inc.) with a combined value of $1.78B across 26,884,652 shares. The largest holder is BlackRock, Inc. with a position worth $1.42B (0.02% of their portfolio). Bridgewater Associates, LP opened a new position in the most recent quarter. 4 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$1.78B
Total Shares Held
26,884,652
Institutional Holders
6
Recent Activity
Bridgewater Associates, LPNew Position
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $1.42B | 0.02% | +5.4% |
| 2 | Slate Path Capital LP | $167.54M | 2.26% | -49.3% |
| 3 | BAKER BROS. ADVISORS LP | $144.44M | 0.85% | +30.2% |
| 4 | CITADEL ADVISORS LLC | $51.46M | 0.01% | +52.4% |
| 5 | Bridgewater Associates, LP | $3.98M | 0.01% | New |
| 6 | Point72 Asset Management, L.P. | $2.12M | 0.00% | +0.0% |